BiotechTubeBiotechTube
Home/Agios Pharmaceuticals/Rahul Ballal, Ph.D.
RB

Rahul Ballal, Ph.D.

Board of Directors

Agios Pharmaceuticals

Therapeutic Areas

Rare DiseasesHematologyHemolytic Anemias

Agios Pharmaceuticals Pipeline

DrugIndicationPhase
Pyrukynd (mitapivat)Hemolytic anemia in adults with Pyruvate Kinase (PK) DeficiencyApproved
MitapivatNon-Transfusion-Dependent ThalassemiaPhase 3
AG-946Hemolytic Anemias and other indicationsPhase 1

Leadership Team at Agios Pharmaceuticals

BG
Brian Goff
Chief Executive Officer
CJ
Cecilia Jones
Chief Financial Officer
SG
Sarah Gheuens, M.D., Ph.D.
Chief Medical Officer, Head of R&D
TM
Tsveta Milanova
Chief Commercial Officer
KV
Krishnan Viswanadhan, Pharm.D.
Chief Corporate Development and Strategy Officer
JB
Jim Burns
Chief Legal Officer
CP
Clive Patience, Ph.D.
Chief Technical Operations Officer
EL
Ellen Lopresti
Chief People Officer
JC
Jeffrey Capello
Board of Directors
KF
Kaye Foster
Board of Directors
View full Agios Pharmaceuticals profile